BPMC Insider Trading Activity and SEC Form 4 Filings
BPMC insider trading summary
No open-market insider purchases or sales of Blueprint Medicines Corp (BPMC) have been reported on SEC Form 4 in the past 12 months.
Latest BPMC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 3, 2025 | Christina Rossi | Chief Operating Officer | Sell | $150K (1,172 @ $128.25) |
| Jul 3, 2025 | Percy H. Carter | Chief Scientific Officer | Sell | $135K (1,051 @ $128.25) |
| Jun 3, 2025 | Percy H. Carter | Chief Scientific Officer | Sell | $309K (2,418 @ $127.88) |
| Jun 3, 2025 | Percy H. Carter | Chief Scientific Officer | Sell | $31K (241 @ $127.88) |
| May 27, 2025 | Jeffrey W. Albers | Insider | Sell | $66K (650 @ $101.93) |
| May 27, 2025 | Jeffrey W. Albers | Insider | Sell | $439K (4,350 @ $101.02) |
| May 19, 2025 | Christina Rossi | Chief Operating Officer | Sell | $142K (1,413 @ $100.67) |
| May 19, 2025 | Christina Rossi | Chief Operating Officer | Sell | $6K (57 @ $101.72) |
| May 19, 2025 | Christina Rossi | Chief Operating Officer | Sell | $81K (804 @ $100.14) |
| May 5, 2025 | Christina Rossi | Chief Operating Officer | Sell | $61K (607 @ $100.97) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.